Roberto Tonelli, Giulia Bruzzi, Riccardo Fantini, Luca Tabbì, Antonio Moretti, Francesco Livrieri, Ivana Castaniere, Stefania Cerri, Daniele Puggioni, Federico Guidotti, Gianluca Bellesia, Alessandro Marchioni, Enrico Clini
{"title":"Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure.","authors":"Roberto Tonelli, Giulia Bruzzi, Riccardo Fantini, Luca Tabbì, Antonio Moretti, Francesco Livrieri, Ivana Castaniere, Stefania Cerri, Daniele Puggioni, Federico Guidotti, Gianluca Bellesia, Alessandro Marchioni, Enrico Clini","doi":"10.1016/j.ejim.2025.02.016","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Monitoring is essential in managing acute hypoxemic respiratory failure (AHRF). Nasal pressure swing (P<sub>nose</sub>) may predict high-flow nasal oxygen (HFNO) therapy failure and respiratory support dependency. This study investigates P<sub>nose</sub>'s predictive value for respiratory support needs and clinical outcomes in AHRF patients initially treated with HFNO.</p><p><strong>Methods: </strong>This post-hoc analysis included 60 AHRF patients treated with HFNO. Respiratory variables, including P<sub>nose</sub>, were assessed at baseline and two hours after HFNO initiation. Patients were classified into high (HG) and low (LG) Pnose groups based on a 5.1 cmH2O threshold. The primary outcome was RS-free survival at day 7; HFNO failure, escalation to non-invasive ventilation (NIV) or mechanical ventilation (MV), mortality, and HFNO weaning time were also analyzed. Predictive accuracy of respiratory indices, including P<sub>nose</sub>, was evaluated.</p><p><strong>Results: </strong>Out of the patients enrolled, 35 were in the HG, and 25 in LG group. HG patients showed a lower RS-free survival at day 7 (adjusted HR=0.26, p < 0.0001), and experienced higher failure rates of HFNO (88 % versus 0 %, p < 0.0001), escalation to NIV (84 % versus 0 %, p < 0.0001), endotracheal intubation (36 % versus 0 %, p < 0.0001), and mortality (24 % versus 6 %, p = 0.0001) compared to LG. Accordingly, RS-free days at day 28 were lower in HG (11 days versus 23 days, p < 0.0001). Finally, among the respiratory variables, P<sub>nose</sub> resulted independently associated with the primary outcome (OR=0.64 95 %CI [0.42-0.90], p = 0.02).</p><p><strong>Conclusions: </strong>In patients with AHRF admitted to the ward and treated by HFNO, P<sub>nose</sub> is an independent and accurate factor in forecasting the dependency from RS and survival within the first week.</p>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":" ","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejim.2025.02.016","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Monitoring is essential in managing acute hypoxemic respiratory failure (AHRF). Nasal pressure swing (Pnose) may predict high-flow nasal oxygen (HFNO) therapy failure and respiratory support dependency. This study investigates Pnose's predictive value for respiratory support needs and clinical outcomes in AHRF patients initially treated with HFNO.
Methods: This post-hoc analysis included 60 AHRF patients treated with HFNO. Respiratory variables, including Pnose, were assessed at baseline and two hours after HFNO initiation. Patients were classified into high (HG) and low (LG) Pnose groups based on a 5.1 cmH2O threshold. The primary outcome was RS-free survival at day 7; HFNO failure, escalation to non-invasive ventilation (NIV) or mechanical ventilation (MV), mortality, and HFNO weaning time were also analyzed. Predictive accuracy of respiratory indices, including Pnose, was evaluated.
Results: Out of the patients enrolled, 35 were in the HG, and 25 in LG group. HG patients showed a lower RS-free survival at day 7 (adjusted HR=0.26, p < 0.0001), and experienced higher failure rates of HFNO (88 % versus 0 %, p < 0.0001), escalation to NIV (84 % versus 0 %, p < 0.0001), endotracheal intubation (36 % versus 0 %, p < 0.0001), and mortality (24 % versus 6 %, p = 0.0001) compared to LG. Accordingly, RS-free days at day 28 were lower in HG (11 days versus 23 days, p < 0.0001). Finally, among the respiratory variables, Pnose resulted independently associated with the primary outcome (OR=0.64 95 %CI [0.42-0.90], p = 0.02).
Conclusions: In patients with AHRF admitted to the ward and treated by HFNO, Pnose is an independent and accurate factor in forecasting the dependency from RS and survival within the first week.
期刊介绍:
The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.